DK0716094T3 - Fremgangsmåde til oprensning af Hepatitis B-virus-overfladeantigen, som omfatter præS2-peptid - Google Patents

Fremgangsmåde til oprensning af Hepatitis B-virus-overfladeantigen, som omfatter præS2-peptid

Info

Publication number
DK0716094T3
DK0716094T3 DK95119383T DK95119383T DK0716094T3 DK 0716094 T3 DK0716094 T3 DK 0716094T3 DK 95119383 T DK95119383 T DK 95119383T DK 95119383 T DK95119383 T DK 95119383T DK 0716094 T3 DK0716094 T3 DK 0716094T3
Authority
DK
Denmark
Prior art keywords
surface antigen
virus surface
antigen including
pres2 peptide
purifying hepatitis
Prior art date
Application number
DK95119383T
Other languages
English (en)
Inventor
Soon-Jae Park
Young-Mee Lee
Kyung-Hee Yoon
Kook-Jin Lim
Young-Sun Kwon
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Application granted granted Critical
Publication of DK0716094T3 publication Critical patent/DK0716094T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95119383T 1994-12-10 1995-12-08 Fremgangsmåde til oprensning af Hepatitis B-virus-overfladeantigen, som omfatter præS2-peptid DK0716094T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR19940033594 1994-12-10

Publications (1)

Publication Number Publication Date
DK0716094T3 true DK0716094T3 (da) 2004-07-26

Family

ID=19400952

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95119383T DK0716094T3 (da) 1994-12-10 1995-12-08 Fremgangsmåde til oprensning af Hepatitis B-virus-overfladeantigen, som omfatter præS2-peptid

Country Status (22)

Country Link
US (1) US6362320B1 (da)
EP (1) EP0716094B1 (da)
KR (1) KR960023066A (da)
CN (1) CN1057532C (da)
AR (1) AR002006A1 (da)
AT (1) ATE264341T1 (da)
BG (1) BG63699B1 (da)
BR (1) BR9505739A (da)
CA (1) CA2164672C (da)
CO (1) CO4480040A1 (da)
CZ (1) CZ291024B6 (da)
DE (1) DE69532878T2 (da)
DK (1) DK0716094T3 (da)
ES (1) ES2217272T3 (da)
JO (1) JO1885B1 (da)
PE (1) PE56396A1 (da)
PL (1) PL182103B1 (da)
PT (1) PT716094E (da)
RO (1) RO113308B1 (da)
RU (1) RU2122430C1 (da)
TR (1) TR199501557A2 (da)
UY (1) UY24112A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA79735C2 (uk) * 2000-08-10 2007-07-25 Глаксосмітклайн Байолоджікалз С.А. Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах
KR100405174B1 (ko) * 2001-02-02 2003-11-12 씨제이 주식회사 재조합 β형 간염바이러스 표면항원의 정제방법
KR20070012838A (ko) * 2004-05-19 2007-01-29 가부시끼가이샤 센단세메이가가꾸겐큐죠 Ｂ형간염 바이러스의 검출방법
GB0522765D0 (en) * 2005-11-08 2005-12-14 Chiron Srl Combination vaccine manufacture
KR100948127B1 (ko) * 2007-06-27 2010-03-18 주식회사 중앙백신연구소 복합호흡기 질환 돼지의 조직유제를 함유하는 백신 조성물
CN104968403A (zh) 2012-09-17 2015-10-07 格雷斯公司 色谱介质和装置
FR2997222B1 (fr) * 2012-10-19 2015-01-16 Alstom Technology Ltd Dispositif d'etablissement et/ou de coupure de courant a contacts permanents a usure reduite
WO2015168383A1 (en) 2014-05-02 2015-11-05 W. R. Grace & Co.-Conn. Functionalized support material and methods of making and using functionalized support material
KR102566292B1 (ko) 2015-06-05 2023-08-10 더블유.알. 그레이스 앤드 캄파니-콘. 흡착성 바이오프로세싱 정화제와 이의 제조 및 사용 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340926A (en) * 1983-03-25 1994-08-23 Celltech, Limited Process for the recovery of recombinantly produced protein from insoluble aggregate
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
ES2043808T3 (es) * 1987-03-09 1994-01-01 Merck & Co Inc Purificacion de antigeno superficial de hepatitis b recombinante.
EP0310178A1 (en) * 1987-09-30 1989-04-05 Merck & Co. Inc. Recovery of pres2+S antigen
EP0314240A3 (en) * 1987-10-26 1990-03-28 Merck & Co. Inc. Process for purifying recombinant hepatitis antigens
US5004688A (en) * 1988-04-15 1991-04-02 Phillips Petroleum Company Purification of hepatitis proteins
US5030720A (en) * 1988-09-01 1991-07-09 Merck & Co., Inc. Pres2+S hepatitis B vaccine derived from plasma
EP0384058A1 (en) * 1989-02-09 1990-08-29 Development Center For Biotechnology Isolation of hepatitis B surface antigen from transformed yeast cells
CU22290A1 (es) * 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal

Also Published As

Publication number Publication date
RU2122430C1 (ru) 1998-11-27
BG100212A (bg) 1996-12-31
PE56396A1 (es) 1996-12-14
CA2164672A1 (en) 1996-06-11
ES2217272T3 (es) 2004-11-01
DE69532878T2 (de) 2005-06-09
CN1057532C (zh) 2000-10-18
PT716094E (pt) 2004-08-31
ATE264341T1 (de) 2004-04-15
BR9505739A (pt) 1997-12-23
CZ324795A3 (en) 1996-06-12
BG63699B1 (bg) 2002-09-30
CA2164672C (en) 2004-06-22
PL311735A1 (en) 1996-06-24
RO113308B1 (ro) 1998-06-30
UY24112A1 (es) 1996-05-10
PL182103B1 (pl) 2001-11-30
JO1885B1 (en) 1997-12-15
EP0716094A1 (en) 1996-06-12
CN1132211A (zh) 1996-10-02
AR002006A1 (es) 1998-01-07
EP0716094B1 (en) 2004-04-14
KR0177254B1 (da) 1999-04-01
DE69532878D1 (de) 2004-05-19
CO4480040A1 (es) 1997-07-09
TR199501557A2 (tr) 1997-03-21
KR960023066A (ko) 1996-07-18
US6362320B1 (en) 2002-03-26
CZ291024B6 (cs) 2002-12-11

Similar Documents

Publication Publication Date Title
ID21649A (id) Inhibitor serum protease, terutama virus hepatitis c ns3 protease
DK1659178T3 (da) Fremgangsmåde til oprensning eller fremstilling af et MAGE-protein
DK0914189T3 (da) Fremgangsmåde til genvinding af procesvæsker
NO976060D0 (no) Vaksiner mot hepatitt C
DK0916675T3 (da) Fremgangsmåde til fremstilling af sildenafil
NO983141L (no) Antigene peptider
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
DK0775100T3 (da) Fremgangsmåde til fremstilling af trifluorethylen
DK0747119T3 (da) Fremgangsmåde til fremstilling af sorberingsmidler
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK0923978T3 (da) Fremgangsmåde til behandling af röggas
ZA9811316B (en) Novel hepatitis C virus NS5B protein
DK0716094T3 (da) Fremgangsmåde til oprensning af Hepatitis B-virus-overfladeantigen, som omfatter præS2-peptid
DK0789767T3 (da) Fremgangsmåde til fremstilling af oprensede papilomavirusproteiner
DE69738312D1 (de) Hepatitis b monoklonale antikörper
DK1027315T3 (da) Fremgangsmåde til fremstilling af n-butanol
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
DK0862939T3 (da) Fremgangsmåde til behandling af röggas
EP0754243A4 (en) METHOD FOR DIAGNOSING CHRONIC HEPATITIS B VIRUS INFECTION
ATE240392T1 (de) Spezifische oligonukleotide fuer hepatitis c- virus
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0881882T3 (da) Fremgangsmåde til bekæmpelse af skadelige organismer ved anvendelse af cycliske polysiloxaner
DK0975618T3 (da) Ny fremgangsmåde til fremstilling af 3-N,N-dicyclobutylamino-8-fluor-3,4-dihydro-2H-1-benzopyran-5-carboxamid
FI943929A0 (fi) Hepatiitti C-viruspeptidejä
FI952778A (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi